Vascular Closure Systems, Inc. Announces Conclusion of Phase I of the First in Human (FIH) Use of the FastSeal® Bioabsorbable Vascular Access Closure System

PALO ALTO, Calif.--(BUSINESS WIRE)--Vascular Closure Systems, Inc.: First in Human (FIH) Use of the FastSeal® Bioabsorbable Vascular Access Closure System – 100% Success Rate, Including Patients with Challenging Anatomy and Vessel Condition.
MORE ON THIS TOPIC